Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| classical monocyte | 28 studies | 67% ± 21% | |
| non-classical monocyte | 24 studies | 51% ± 17% | |
| conventional dendritic cell | 23 studies | 42% ± 19% | |
| monocyte | 18 studies | 60% ± 15% | |
| basal cell | 17 studies | 42% ± 23% | |
| dendritic cell | 16 studies | 40% ± 16% | |
| macrophage | 15 studies | 38% ± 20% | |
| myeloid cell | 9 studies | 45% ± 21% | |
| neutrophil | 8 studies | 53% ± 19% | |
| alveolar macrophage | 5 studies | 45% ± 17% | |
| club cell | 5 studies | 52% ± 16% | |
| epithelial cell | 5 studies | 56% ± 36% | |
| respiratory goblet cell | 5 studies | 31% ± 5% | |
| secretory cell | 5 studies | 48% ± 25% | |
| intermediate monocyte | 5 studies | 68% ± 27% | |
| keratinocyte | 5 studies | 37% ± 13% | |
| squamous epithelial cell | 4 studies | 62% ± 22% | |
| mononuclear phagocyte | 4 studies | 49% ± 18% | |
| ciliated cell | 3 studies | 48% ± 21% | |
| serous secreting cell | 3 studies | 28% ± 16% | |
| hematopoietic precursor cell | 3 studies | 44% ± 7% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| lung | 71% | 642.05 | 408 / 578 | 54% | 223.95 | 620 / 1155 |
| esophagus | 42% | 53063.64 | 610 / 1445 | 66% | 520.48 | 121 / 183 |
| skin | 78% | 6364.76 | 1414 / 1809 | 20% | 42.97 | 93 / 472 |
| tonsil | 0% | 0 | 0 / 0 | 98% | 1357.65 | 44 / 45 |
| bladder | 24% | 248.86 | 5 / 21 | 60% | 124.70 | 302 / 504 |
| lymph node | 0% | 0 | 0 / 0 | 72% | 63.35 | 21 / 29 |
| liver | 22% | 172.02 | 50 / 226 | 50% | 27.34 | 201 / 406 |
| peripheral blood | 69% | 1652.59 | 638 / 929 | 0% | 0 | 0 / 0 |
| uterus | 2% | 959.72 | 3 / 170 | 64% | 517.29 | 294 / 459 |
| prostate | 43% | 418.38 | 105 / 245 | 22% | 10.56 | 112 / 502 |
| breast | 34% | 300.99 | 155 / 459 | 28% | 24.95 | 309 / 1118 |
| pancreas | 1% | 7.63 | 2 / 328 | 53% | 30.48 | 95 / 178 |
| ovary | 39% | 352.38 | 71 / 180 | 14% | 5.28 | 59 / 430 |
| spleen | 41% | 390.41 | 98 / 241 | 0% | 0 | 0 / 0 |
| adipose | 34% | 320.89 | 415 / 1204 | 0% | 0 | 0 / 0 |
| thymus | 1% | 9.87 | 6 / 653 | 15% | 16.37 | 89 / 605 |
| stomach | 7% | 194.60 | 26 / 359 | 8% | 5.04 | 23 / 286 |
| intestine | 1% | 10.60 | 11 / 966 | 11% | 41.55 | 59 / 527 |
| kidney | 0% | 0 | 0 / 89 | 5% | 1.87 | 42 / 901 |
| blood vessel | 4% | 36.43 | 52 / 1335 | 0% | 0 | 0 / 0 |
| brain | 0% | 1.65 | 5 / 2642 | 4% | 1.20 | 26 / 705 |
| adrenal gland | 0% | 2.61 | 1 / 258 | 3% | 1.84 | 8 / 230 |
| muscle | 0% | 15.67 | 4 / 803 | 0% | 0 | 0 / 0 |
| heart | 0% | 3.10 | 4 / 861 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
| GO_0030216 | Biological process | keratinocyte differentiation |
| GO_0018149 | Biological process | peptide cross-linking |
| GO_0045861 | Biological process | negative regulation of proteolysis |
| GO_0098609 | Biological process | cell-cell adhesion |
| GO_0010466 | Biological process | negative regulation of peptidase activity |
| GO_0001533 | Cellular component | cornified envelope |
| GO_0005615 | Cellular component | extracellular space |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005829 | Cellular component | cytosol |
| GO_1904090 | Cellular component | peptidase inhibitor complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0002020 | Molecular function | protease binding |
| GO_0004869 | Molecular function | cysteine-type endopeptidase inhibitor activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | CSTA |
| Protein name | Cystatin A Cystatin-A (Cystatin-AS) (Stefin-A) [Cleaved into: Cystatin-A, N-terminally processed] |
| Synonyms | STF1 STFA |
| Description | FUNCTION: This is an intracellular thiol proteinase inhibitor. Has an important role in desmosome-mediated cell-cell adhesion in the lower levels of the epidermis. . |
| Accessions | C9J0E4 ENST00000479204.1 P01040 ENST00000264474.4 |